Bromodeoxyuridine-induced changes in the transformed phenotype.
D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002999:Clone Cells; D003260:Contact Inhibition / Q000187:drug effects; D003599:Cytoskeleton / Q000032:analysis / Q000187:drug effects; D005353:Fibronectins / Q000032:analysis; D006020:Glycopeptides / Q000032:analysis; D008099:Liver; D008565:Membrane Proteins / Q000032:analysis; D008871:Microvilli / Q000187:drug effects; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010641:Phenotype; D051381:Rats
D005353:Fibronectins; D006020:Glycopeptides; D008565:Membrane Proteins; D009955:Ornithine Decarboxylase; D001973:Bromodeoxyuridine